Goldman Sachs’s Bioceres Crop Solutions BIOX Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOX
SP
LFCM
Goldman Sachs's BIOX Position: Q3 2026 in Review
Goldman Sachs sold out of Bioceres Crop Solutions (BIOX) in Q3 2026, closing a stake of 129,445 shares — an estimated $45.3K sold.
Goldman Sachs first reported a position in BIOX in Q2 2023 and held it in 10 quarters. The position peaked at $271K in Q1 2024. 27 funds tracked by Wall St. Rank hold BIOX as of Q3 2026.
- Goldman Sachs reported no remaining Bioceres Crop Solutions position as of Q3 2026 after selling out during the quarter.
- Goldman Sachs sold 129,445 Bioceres Crop Solutions shares in Q3 2026, an estimated $45.3K.
- Goldman Sachs first reported a position in Bioceres Crop Solutions in Q2 2023 and held it in 10 quarters.
- Goldman Sachs's Bioceres Crop Solutions position peaked at $271K in Q1 2024.
- 27 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q3 2026.
Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.